Inventor

MOSER RUDOLF

CH47 patents

⚠️ This page may combine multiple inventors who share the name “MOSER RUDOLF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MOSER RUDOLF

Merck & Cie

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

Stable salt of 5,10-methylene-(6R)-tetrahydrofolic acid

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

18F-labelled folates as PET radiotracers

18F-saccharide-folates

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

Process for the preparation of optically pure tetrahydropterins and derivatives, and specifically of optically pure tetrahydrofolic acid and derivatives thereof, by stereospecific hydrogenation

18F-labelled folates

Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl-(6S)-tetrahydrofolate

18F-labelled folate/antifolate analogues

18F-labelled folates

MERCK PATENT GMBH

Stable lyophilisates comprising 5,10-methylene-(6R)-tetrahydrofolic acid

Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester

Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and l-leucine ethyl ester

Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester

Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino ethyl esters

Crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid and 4-(2-hydroxyethyl)-morpholine

Crystalline sodium salt of 5-methyl-(6S)-tetrahydrofolic acid

Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid

Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid

Crystalline binary sodium salts of 5-methyl-(6S)-tetrahydrofolic acid with organic bases

Isomerically pure 18F-labelled tetrahydrofolates

EPROVA AG

Stable crystalline salts of 5-methyltetrahydrofolic acid

Use of tetrahydrofolates in natural stereoisomeric form for the production of a pharmaceutical preparation suitable for influencing the homocysteine level, particularly for assisting the remethylation of homocysteine

Stable crystalline (6S)- and (6R)-tetrahydrofolic acid

Stable crystalline tetrahydrofolic acid salts

Stable crystalline (6R) -tetrahydrofolic acid

Process for the preparation of pure stereoisomers of tetrahydrofolic acid esters salts and tetrahydrofolic acid by fractionated crystallization of tetrahydrofolic acid esters salts

MOSER RUDOLF

Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride

Stable pharmaceutical compositions of 5,10-methylene tetrahydrofolate

Tool for machining a work piece and method for machining a work piece

Method for cell-specific targeting

BIOMARIN PHARM INC

Methods and compositions for the treatment of metabolic disorders

Methods and compositions for the treatment of metabolic disorders

Process for preparing tetrahydrobiopterin and analogs of tetrahydrobiopterin

MERCK EPROVA AG

Crystalline forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride

18F-labelled folates

Process for preparing crystalline polymorphic forms of (6R)-L-erythro-tetrahydrobiopterin dihydrochloride

OPPENHEIMER DANIEL I

Methods and compositions for the treatment of metabolic disorders

Methods and compositions for the treatment of metabolic disorders

SCHIBLI ROGER

Folate conjugates of albumin-binding entities

18F-saccharide-folates

EPROV AG

Pharmaceutical preparation for treating or preventing cardiovascular or neurological disorders by modulating of the activity of nitric oxide synthase

EPROV A G

Pharmaceutical preparation containing at least folic acid or a folate and tetrahydrobiopterin (BH4) or derivatives thereof used for the treating or preventing cardiovascular or neurological disorders by modulation of the activity of nitric oxide synthase (NOS)

AMETAMEY SIMON MENSAH

18F-labelled folates